Frankfurt
23.03.26 | 08:15
0,000 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,005 | 0,036 | 12:02 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.03. | KDventures AB: KDventures' portfolio company AnaCardio extends IP protection for AC01 until the 2040s with new US patent approval | 89 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN March 11, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that its portfolio company AnaCardio has received approval for a US patent covering the use of AC01 for the treatment... ► Artikel lesen | |
| 03.03. | KDventures AB: KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos' drug candidate for PCOS | 234 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, March 3, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that Organon has discontinued the development of a preclinical drug candidate for polycystic ovarian syndrome... ► Artikel lesen | |
| 27.02. | Change of number of shares and votes in KDventures AB | 1 | GlobeNewswire (USA) | ||
| 24.02. | KDventures AB: KDventures's portfolio company SVF Vaccines announces that the intended merger with Novakand will not be carried out following negative decision from Nasdaq | 221 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, February 24, 2026. KDventures AB (Nasdaq Stockholm: KDV) announces that the planned reversed acquisition of the portfolio company SVF Vaccines by Novakand Pharma will not be completed... ► Artikel lesen | |
| 13.02. | KDventures AB: Year-end Report - January-December 2025 | 181 | GlobeNewswire (Europe) | STOCKHOLM - 13 February 2025. KDventures AB (Nasdaq Stockholm: KDV) today publishes its Year-end Report January-December 2025. The full report is available on the Company's website. "A stronger financial... ► Artikel lesen | |
| KDVENTURES Aktie jetzt für 0€ handeln | |||||
| 12.02. | KDventures AB (publ): KDventures AB (publ) carries out a directed issue of shares to guarantors in connection with the completed rights issue | 204 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 10.02. | KDventures AB (publ): KDventures' portfolio company SVF Vaccines appoints Raheleh Nassaji as Chief Executive Officer | 268 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 10 February 2026. KDventures AB (Nasdaq Stockholm: KDV) announces that its portfolio company SVF Vaccines has appointed Raheleh Nassaji as Chief Executive Officer to lead the transition... ► Artikel lesen | |
| 09.02. | Change of issuer name and symbol for Karolinska Development AB | 238 | GlobeNewswire | As from February 10, 2026, Karolinska Development AB will change issuer name and symbol.
Old issuer name: Karolinska Development AB
New issuer name: KDventures AB
Old symbol: KDEV
New symbol: KDV
ISIN... ► Artikel lesen | |
| 06.02. | Karolinska Development AB (publ): Karolinska Development's portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement | 182 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, February 6, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has entered into a reverse acquisition agreement with Novakand... ► Artikel lesen | |
| 28.01. | Karolinska Development AB: Karolinska Development AB (publ) announces the outcome of the rights issue and change of the company name to KDventures AB | 300 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 23.01. | Karolinska Development AB (publ): Karolinska Development AB receives additional guarantee commitments in ongoing rights issue | 371 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 21.01. | Karolinska Development AB (publ): Karolinska Development's portfolio company Dilafor signs binding term sheet with Exeltis for a license agreement regarding tafoxiparin | 186 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - January 21, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has signed a binding term sheet with Exeltis, a global Women's... ► Artikel lesen | |
| 13.01. | The subscription period in Karolinska Development AB (publ)'s rights issue begins today | 1 | GlobeNewswire (USA) | ||
| 12.01. | Listing of subscription rights and paid subscription shares of Karolinska Development AB | 263 | GlobeNewswire | With effect from January 13, 2026, the subscription rights of Karolinska Development AB will be traded on the list for Equity rights. Trading will continue up until and including January 22, 2026.
... ► Artikel lesen | |
| 09.01. | Karolinska Development AB (publ) announces publication of information document in connection with upcoming rights issue | 193 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 08.01. | Karolinska Development AB (publ): Karolinska Development's Extraordinary General Meeting 2026 | 312 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - January 8, 2026. Karolinska Development AB (publ) ("Karolinska Development" or the "Company") held an Extraordinary General Meeting on January 8, 2026, at which the shareholders... ► Artikel lesen | |
| 07.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.01.2026 | 632 | Xetra Newsboard | Das Instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON EQUITY wird cum Kapitalmassnahme gehandelt am 07.01.2026 und ex Kapitalmassnahme am 08.01.2026 The instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON... ► Artikel lesen | |
| 22.12.25 | Karolinska Development AB (publ): Karolinska Development's portfolio company SVF Vaccines plans for listing on Nasdaq First North Premier through reverse takeover ahead of accelerated vaccine development | 210 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has signed a non-binding letter of intent (LOI) with Novakand... ► Artikel lesen | |
| 11.12.25 | Karolinska Development AB (publ): Karolinska Development's portfolio company SVF Vaccines presents new preclinical data demonstrating extended effect of SVF-001 in chronic hepatitis B and D | 214 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, December 11, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has presented new preclinical data on its immunotherapy SVF-001... ► Artikel lesen | |
| 10.12.25 | Karolinska Development AB (publ): Karolinska Development's portfolio company Modus Therapeutics initiates dosing in phase 2a study in patients with chronic kidney disease with anemia | 232 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN December 10, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has dosed the first patient in the phase 2a... ► Artikel lesen |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NAKIKI | 0,331 | -12,20 % | NAKIKI SE im Fokus: Schwäche mit Substanzprüfung | ||
| AIFINYO | 1,600 | -1,23 % | DEWB: Wertberichtigungsbedarf bei aifinyo belastet Jahresergebnis | Nächste Gewinnwarnung nun auch bei der Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG (ISIN: DE000 A41YCR 9): So werde das 2025er-Jahresergebnis durch eine außerplanmäßige Abschreibung im... ► Artikel lesen | |
| ISHARES BITCOIN TRUST | 39,770 | 0,00 % | Steht Morgan Stanleys "Monster-Bitcoin" vor der Tür? Der CEO für Strategie sagt, dass ein Zufluss von 160 Milliarden Dollar das Volumen des Blackrock IBIT verdreifachen könnte | ||
| ALLIANZ | 340,60 | -3,57 % | Allianz: Durchbruch in Indien - Aktie vor neuem Anlauf? | Die Allianz treibt ihre Expansion in Indien weiter voran. Das gemeinsam mit Jio Financial Services gegründete Rückversicherungsunternehmen Allianz Jio Reinsurance hat von der indischen Aufsichtsbehörde... ► Artikel lesen | |
| DEUTSCHE BANK | 23,855 | -5,15 % | EQS-CMS: Deutsche Bank AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Deutsche Bank AG
/ Aktienrückkauf - Wochenbericht
Deutsche Bank AG: Veröffentlichung einer Kapitalmarktinformation
16.03.2026 / 16:58... ► Artikel lesen | |
| HERITAGE FINANCIAL | 24,690 | 0,00 % | Heritage Financial Corporation Announces Completion of Acquisition of Olympic Bancorp, Inc. | OLYMPIA, Wash., Feb. 2, 2026 /PRNewswire/ -- Heritage Financial Corporation ("Heritage") (Nasdaq: HFWA) announced that effective January 31, 2026, it completed... ► Artikel lesen | |
| LAKELAND FINANCIAL | 55,30 | 0,00 % | Lakeland Financial Reports Record Quarterly Performance with a 24% Increase in Net Income; Annual Net Income Grows by 11% to $103.4 Million, as Net Interest Income Expands by 12% | WARSAW, Ind., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Lakeland Financial Corporation (Nasdaq Global Select/LKFN), parent company of Lake City Bank, today reported record quarterly net income of $29.9 million... ► Artikel lesen | |
| MUENCHENER RUECK | 511,60 | -3,40 % | Munich Re: Neubewertung notwendig? | Der eskalierende Nahostkonflikt könnte für Bewegung im globalen Rückversicherungsmarkt sorgen - und damit auch für die Aktie von Munich Re. Eine neue Analyse der Ratingagentur AM Best deutet darauf... ► Artikel lesen | |
| DEUTSCHE BOERSE | 244,30 | -1,97 % | EQS-CMS: Deutsche Börse AG: Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014 / | EQS Zulassungsfolgepflichtmitteilung: Deutsche Börse AG
/ Erwerb eigener Aktien
Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014 /
16.03.2026... ► Artikel lesen | |
| COMMERZBANK | 29,470 | -5,42 % | EQS-WpÜG: Übernahmeangebot / Zielgesellschaft: COMMERZBANK Aktiengesellschaft; Bieter: UniCredit S.p.A. | EQS-WpÜG: UniCredit S.p.A. / Übernahmeangebot
Übernahmeangebot / Zielgesellschaft: COMMERZBANK Aktiengesellschaft; Bieter: UniCredit S.p.A.
16.03.2026 / 07:50 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| XETRA-GOLD | 119,91 | -3,96 % | Xetra Gold (4GLD): Der Goldrausch 2026 startet in die nächste Phase! | Kursziel Allzeithoch! Rückblick Als Inhaber-Schuldverschreibung, die einen Auslieferungsanspruch auf physisches Gold verbrieft, ist der Xetra Gold- ETC ein klassisches Instrument für Anleger, die von... ► Artikel lesen | |
| FIRST BANCORP | 52,71 | 0,00 % | First Bancorp Reports Fourth Quarter and Full Year Results | Fourth Quarter 2025 Financial Data
(Dollars in 000s, except per share data)
Q4-2025
Q3-2025
Q4-2024
Summary Income Statement
... ► Artikel lesen | |
| DIREXION DAILY S&P 500 BEAR 3X | 41,420 | 0,00 % | Direxion Daily S&P 500 Bear 3X Shares declares quarterly distribution of $0.1934 | ||
| VANECK MORNINGSTAR DEVELOPED MARKETS DIVIDEND LEADERS | 50,50 | -0,86 % | Ich empfehle den VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF: "Welt-Aktien" mit hoher Konzentration ... | ||
| REAL ESTATE SELECT SECTOR SPDR FUND | 40,605 | 0,00 % | The Real Estate Select Sector SPDR Premium Income Fund declares monthly distribution of $0.2372 |
Das Unternehmen KDVENTURES AB kann der Branche Finanzdienstleistungen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KDVENTURES AB finden Sie auf Wallstreet Online.